Skip to Content

Prostate Cancer

Our Approach

Radiation oncologist Deborah Kuban, M.D.(center), and surgeon John Davis, M.D., are part of a team of skilled experts offering personalized, comprehensive prostate cancer care.

From your first visit to MD Anderson's Genitourinary Cancer Center for prostate cancer screening, diagnosis and treatment, you are the focus of an incredible team of experts that personalizes every aspect of your care especially for your unique situation. This greatly increases your chances for successful treatment and recovery.

This specialized group communicates and collaborates closely – with you and each other – to be sure you receive the most advanced prostate cancer care with the least impact on your body. Your team includes medical, surgical and radiation oncologists, as well as a specially trained support staff. They work with the latest technology and techniques, including:

  • Open prostatectomy (often with nerve-sparing techniques)
  • Minimally invasive laparoscopic robotic prostatectomy
  • Intensity modulated radiation therapy (IMRT)
  • Proton therapy
  • Brachytherapy
  • Cryotherapy
  • Targeted therapies
  • Vaccine therapy
  • Hormonal therapy
  • Active surveillance

Investigating the Future

We are proud to be one of the few cancer centers in the nation to house a prestigious federally funded prostate cancer SPORE (Specialized Program of Research Excellence) program. We're studying new ways to prevent, diagnose and treat prostate cancers to give patients the most-advanced treatments with the least impact on the body.

And at MD Anderson you're surrounded by the strength of one of the nation's largest and most experienced comprehensive cancer centers, which has all the support and wellness services needed to treat the whole person – not just the disease.

If you have been diagnosed with prostate cancer, we're here to help. Call 1-877-632-6789 to make an appointment or request an appointment online.

Why Choose MD Anderson?

  • Leading-edge prostate cancer treatments including vaccine, gene and proton therapy
  • Minimally invasive, nerve-sparing and sural nerve graft surgical procedures
  • Latest radiotherapy techniques for prostate cancer, including intensity modulated radiation therapy (IMRT) and brachytherapy
  • Team of experts provides personalized care for prostate cancer
  • Clinical trials of new therapies for prostate cancer
  • Prostate cancer is part of MD Anderson's Moon Shots Program: an ambitious effort to reduce cancer deaths through the rapid discovery and implementation of new treatments

Prostate Cancer Knowledge Center

Treatment at MD Anderson

Prostate cancer is treated in our:

Find Your MD Anderson Location


Joe and Marcia Landry

"I never expected to be treated quite so individually. The doctors and nurses are attentive to your individual needs and concerns."

Prostate Cancer Survivor Joe Landry

Prostate Cancer Facts

Prostate cancer is the type of cancer found most often among men in the United States, and more than 192,000 cases are diagnosed each year. It’s second only to lung cancer as a cause of cancer deaths among men in this country.

Chances are that you know someone who has prostate cancer or has been treated for it. One out of every seven American men will be diagnosed with the disease in their lifetime.

The survival rate is increasing, and awareness, screening and improved therapies are some of the reasons. If found early, prostate cancer has a good chance for successful treatment. In fact, prostate cancer sometimes does not pose a significant threat to a man’s life and can be observed carefully instead of treated immediately.

The prostate is a walnut-size gland in the male reproductive system. Just below the bladder and in front of the rectum, it surrounds part of the urethra, a tube that empties urine from the bladder. The prostate helps produce semen and nourish sperm.

The prostate begins to develop while a baby is in his mother’s womb. Fueled by androgens (male hormones), it continues to grow until adulthood.

Sometimes, the part of the prostate around the urethra may keep growing, causing benign prostatic hyperplasia (BPH). While this condition may interfere with passing urine and needs to be treated, it is not prostate cancer.

Prostate Cancer Types

Almost all prostate cancers begin in the gland cells of the prostate and are known as adenocarcinomas.

Pre-cancerous changes of the prostate: By age 50, about half of all men have small changes in the size and shape of the cells in the prostate. This is called prostatic intraepithelial neoplasia (PIN).

Some research has indicated these cellular changes may eventually develop into prostate cancer. But this is controversial, and preventive treatment is not recommended.

If PIN is present, the best strategy is to be certain a thorough biopsy procedure shows no invasive cancer. If PIN is the only finding, then careful follow-up screening with a prostate-specific antigen (PSA) blood test and digital rectal examination (DRE) is recommended.

If you have been diagnosed with prostate cancer, we’re here to help. Call 1-877-632-6789 to make an appointment or request an appointment online.


© 2014 The University of Texas MD Anderson Cancer Center